US-based private equity firm KKR has appointed DS Brar as a senior advisor to the firm.
“DS Brar is one of the most respected business managers in India,” said Sanjay Nayar, head of KKR’s India operations.
“He has a breadth of business, economic and government experience, and we are very pleased he will bring his expertise to bear on our current and prospective investments as a senior advisor to the firm,” he added.
In his new role for KKR, Brar will also serve on the firm’s Asia portfolio management committee, which interacts with company management, monitors the firm’s investments in the region, and provides guidance and input on the operations of the companies.
Brar currently holds board positions in various Indian and international companies. From 2000 to 2007, he served as a director of Reserve Bank of India (RBI) and was also a member of the inspection and audit sub-committee of the central board of directors of the RBI.
He spent the majority of his career with Ranbaxy Laboratories, India’s largest pharmaceutical company, and was named its CEO and managing director in 1999. In 2004 he founded GVK Biosciences, a contract research organization providing discovery & development services to global life sciences companies.
Brar said, “KKR is a premier global investment firm with an outstanding leadership team. I am honored to have the opportunity to work with KKR in bringing value to both Indian and global companies across a broad range of offerings.”
Earlier this month, the firm announced the appointment of Dhiren Mehta as director of KKR India.
Copyright © 2011 AltAssets